Application Value of Serum Metabolic Markers for Cognitive Prediction in Elderly Epilepsy
Hong Wei,Dandan Liu,Leiyu Geng,Yun Liu,Huiqin Wang,Fuling Yan
DOI: https://doi.org/10.2147/NDT.S371751
IF: 2.989
2022-09-22
Neuropsychiatric Disease and Treatment
Abstract:Hong Wei, 1 Dandan Liu, 1, 2 Leiyu Geng, 1 Yun Liu, 1 Huiqin Wang, 1 Fuling Yan 1 1 Department of Neurology, Affiliated ZhongDa Hospital, School of Medicine, Southeast University, Nanjing, People's Republic of China; 2 Department of Neurology, The People's Hospital of Danyang, Affiliated Danyang Hospital of Nantong University, Zhenjiang, People's Republic of China Correspondence: Fuling Yan, Department of Neurology, Affiliated ZhongDa Hospital, School of Medicine, Southeast University, Dingjiaqiao 87, Nanjing, 210009, People's Republic of China, Email Background and Study Aims: Elderly epilepsy is the third most common chronic disease that affects metabolism either alone or through antiepileptic drugs (AEDs). Here, we focus on whether neurocognitive profiles in elderly epilepsy and its treatment are linked to metabolic conditions. Patients and Methods: Elderly patients with epilepsy without cognitive impairment (n = 78) and with cognitive impairment (n = 75) were enrolled. C-reactive protein (CRP) and metabolic markers (triglyceride (TG), total cholesterol (TC), high-density lipoprotein (HDL-c), low-density lipoprotein (LDL-c), albumin, fasting glucose (Glu) and glycosylated hemoglobin (HbA1c)) were measured. Serum markers were modeled using logistic regression analysis. Results: TG, TC, fasting glucose, HbA1c and CRP were significantly increased ( p < 0.05, 0.05, 0.001, 0.001, 0.01, respectively) in elderly epilepsy, whereas HDL-c, LDL-c and serum albumin were decreased ( p < 0.001, 0.001, 0.001) in elderly epilepsy. TG, TC, fasting Glu, HbA1c and CRP were significantly elevated (p < 0.05, 0.001, 0.001, 0.001, 0.001, respectively) in epilepsy with cognitive impairment, whereas HDL-c, LDL-c and serum albumin were decreased (p < 0.001, 0.001, 0.001). The abnormal glycolipid profile was predominated in AED-treated patients. The regression model combined with TG, LDL-c, HDL-c and albumin performed better (area under the ROC curve was 0.824) in AED-treated patients. Conclusion: The relevant relationship between glycolipid profile and cognitive impairment with epilepsy was described, and the logistic regression model based on serum TG, LDL-c, HDL-c and albumin is reported and may serve as promising diagnostic markers for elderly epilepsy with cognitive impairment. Additionally, a specific emphasis on the complex role of altered lipid metabolism and AEDs is made. Keywords: elderly epilepsy, glycolipid metabolic, logistic regression, AED With advances in healthcare and an aging population, the number of the elderly with epilepsy is set to rise substantially across the world. Epilepsy is the third most common neurological disorder and affects 65 million people with a peak incidence that is higher in the older population over 65 years of age. 1,2 A continuous epileptogenic process could irreversibly damage the brain, causing persistent cognitive impairment. 3 Recent findings show an important bidirectional link between cognitive function and epilepsy. Comorbid condition could arise before, concomitantly, or after an epilepsy diagnosis; they may be caused by or a consequence of epilepsy or may be associated with epilepsy because they share common pathologic risk factors or pathogenic process, or they may be discordant conditions. 4,5 Epidemiological findings show that individuals with epilepsy and people with cognitive impairment share common risk factors. 6 The epileptic cognitive impairment theory was first put forward, indicating that cognitive impairment and epilepsy may result from the same underlying impairment. 6 There is a complex interplay between comorbidities in elderly epilepsy, especially elderly epilepsy with cognitive impairment. The elderly epilepsy identified a threshold of over 65 years of age as likely to be the most optimal. 7 Only one detailed report is available on cognitive function in people who first developed epilepsy after the age of 65. 8 Importantly, some findings also suggest that elderly patients with epilepsy are at a higher risk of developing cognitive impairment and ultimately dementia. 9 Indeed, markers for cognitive impairment in epilepsy might not be unique to epilepsy but rather reflect mixed pathologies. Shared markers may be due to the fact that cognitive impairment may share underlying pathological mechanisms with epilepsy. Alternatively, seizures might trigger pathological changes that make the brain more vulnerable to developing cognitive impairment. Thus, molecular cascades important in both seizure generation and cognitive impairment might converge within epileptogenic tissue in elderly patie -Abstract Truncated-
psychiatry,clinical neurology